Your chance to chat with Sue Desmond-Hellman

Dr. Sue Desmond-Hellman is stepping down from her post as CEO of the Bill and Melinda Gates Foundation. Now, the former UCSF chancellor and Genentech president will be fielding questions from STAT Plus subscribers in an exclusive Q&A session.

What was it like to treat patients with AIDS-related cancer in Uganda? What was her role in spearheading the first gene-targeted therapies for cancer? How did she assess possible projects to fund at the Gates Foundation? 

Submit your questions to Desmond-Hellman before Jan. 10 here.